Body

Relaxed blood pressure guidelines cut millions from needing medication

DURHAM, N.C. – New guidelines that ease the recommended blood pressure could result in 5.8 million U.S. adults no longer needing hypertension medication, according to an analysis by Duke Medicine researchers.

The findings are the first peer-reviewed analysis to quantify the impact of guidelines announced in February by the Eighth Joint National Committee. In a divisive move, the committee relaxed the blood pressure goal in adults 60 years and older to 150/90, instead of the previous goal of 140/90.

Study estimates proportion of adults affected by new blood pressure guideline

Applying the updated 2014 blood pressure (BP) guideline to the U.S. population suggests that nearly 6 million adults are no longer classified as needing hypertension medication, and that an estimated 13.5 million adults would now be considered as having achieved goal blood pressure, primarily older adults, according to a JAMA study released online to coincide with the 2014 American College of Cardiology Scientific Sessions.

US, European cholesterol guidelines differ in statin use recommendations

Application of U.S. and European cholesterol guidelines to a European population found that proportions of individuals eligible for statins differed substantially, with one U.S. guideline recommending statins for nearly all men and two-thirds of women, proportions exceeding those of the other guidelines, according to a JAMA study released online to coincide with the 2014 American College of Cardiology Scientific Sessions.

Analysis supports use of risk equations to guide statin therapy

In an analysis of almost 11,000 patients, an assessment of equations that help guide whether a patient should begin taking a statin (cholesterol lowering medication) found that observed and predicted 5-year atherosclerotic cardiovascular disease risks were similar, suggesting that these equations are helpful for clinical decision making, according to a JAMA study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions.

Are statins good for your love life?

Statins are associated with a significant improvement in erectile function, a fact researchers hope will encourage men who need statins to reduce their risk of heart attack to take them, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session.

Too many diet drinks may spell heart trouble for older women

It appears healthy postmenopausal women who drink two or more diet drinks a day may be more likely to have a heart attack, stroke or other cardiovascular problems, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session.

New approach to leukemia testing may better define prognosis, treatment

Augusta, Ga. – Nearly half of patients with the most common form of adult leukemia are said to have normal chromosomes but appear instead to have a distinct pattern of genetic abnormalities that could better define their prognosis and treatment, researchers report.

Commonly used intra-aortic balloon pump may have broader potential for heart patients

Augusta, Ga. – The most frequently used mechanical circulatory assist device in the world may have untapped potential, physicians say.

One of many uses for the intra-aortic balloon pump is helping ensure adequate oxygen and blood delivery to a heart struggling to resume beating in the aftermath of coronary bypass surgery, said Dr. Mary Arthur, cardiovascular anesthesiologist at the Medical College of Georgia and Georgia Regents Health System.

Drilling into the trends in genetics and epigenetics of aging and longevity

Since the dawn of civilization people were searching for clues to longevity and trying to extend human lifespan. But only in the past two decades with the advances in genetic sequencing, epigenetic analysis, and increased government investments the area experienced rapid expansion in the knowledge base, allowing scientists to develop comprehensive models and theories of aging. And while there is still much disagreement among scientists, the evolutionary theories are dominating the field.

NIST issues final Joplin tornado report, begins effort to improve standards and codes

The National Institute of Standards and Technology (NIST) has released the final report on its technical investigation into the impacts of the May 22, 2011, tornado that struck Joplin, Mo. The final report is strengthened by clarifications and supplemental text suggested by organizations and individuals from across the nation in response to the request for comments on the draft Joplin report, released Nov. 21, 2013.

Adjuvant chemotherapy increases markers of molecular aging in the blood of BC survivors

Adjuvant chemotherapy for breast cancer is "gerontogenic", accelerating the pace of physiologic aging, according to a new study published March 28 in the Journal of the National Cancer Institute.

UNC researchers show cancer chemotherapy accelerates 'molecular aging'

Physicians have long suspected that chemotherapy can accelerate the aging process in patients treated for cancer. Using a test developed at UNC Lineberger Comprehensive Cancer Center to determine molecular aging, UNC oncologists have directly measured the impact of anti-cancer chemotherapy drugs on biological aging.

Whether they reduce fat or not, obesity programs lower kids' blood pressure

BUFFALO, N.Y. – One of the serious health consequences of obesity is elevated blood pressure (BP), a particular problem in children because research has found that high BP in children usually follows them into adulthood, carrying with it a wide range of possible negative consequences.

Even modest elevations in the BP of adolescents, according to recent research, can pose cardiovascular problems later in life.

Stigmas, once evolutionarily sound, are now bad health strategies

Stigmatization may have once served to protect early humans from infectious diseases, but that strategy may do more harm than good for modern humans, according to Penn State researchers.

"The things that made stigmas a more functional strategy thousands of years ago rarely exist," said Rachel Smith, associate professor of communication arts and sciences and human development and family studies. "Now, it won't promote positive health behavior and, in many cases, it could actually make the situation worse."

Safety and immunogenicity of 2 doses of the HPV-16/18 AS04 adjuvanted vaccine Cervarix

A recent study in the journal Human Vaccines & Immunotherapeutics, showed that two doses of the HPV-16/18 AS04-adjuvanted vaccine Cervarix (GlaxoSmithKline) are non-inferior to three-doses in the current schedule.